Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McGill University

$135,000.00

Identifying the genetic causes of ataxias using Next-generation sequencing (NGS) methods.

EF 2014-15

Résumé
The human genome is made up of approximately 22,000 functional units known as genes. Mutations in these genes can cause thousands rare but nonetheless serious diseases impacting hundreds of thousands of Canadians. Many of those rare diseases are affecting the nervous system and are called neurodegenerative diseases. Ataxias are part of this group. Patients affected by ataxias mainly suffer of a lack of voluntary coordinate movements due to degeneration of part of the nervous system responsible for this coordination. Many patients are also presenting other neurological symptoms such as mental retardation, sensory impairment, etc. The diagnosis of this group of diseases is difficult due to an important variability in the symptoms even in patients from a same family. For many forms of ataxias, the genes responsible have not yet been identified. In the context of the Care for Rare (C4R) project, a pan-Canadian consortium configured to improve the diagnosis of rare diseases; we are aiming to study the genetic causes of ataxias. We will use new powerful DNA sequencing methods to perform a genetic mutational study of the entire coding exons (exomes) on selected patients. This will enable us to uncover novel causative genes and better describe the clinical variability in those disorders by identifying new mutations in known genes. This work will enhance the quality of genetic counseling for ataxia patients throughout Canada. It will also allow a better understanding of the molecular pathways involved in hereditary ataxias and may lead to novel treatments strategies.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
318747
Name
Tetreault Martine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identifying the genetic causes of ataxias using Next-generation sequencing (NGS) methods.
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Ataxia; Gene Identification; Human Genetics; Mri Anomalies; Neurodegenerative Disorder; Next-Generation Sequencing; Whole-Exome Sequencing
Abstract
The human genome is made up of approximately 22,000 functional units known as genes. Mutations in these genes can cause thousands rare but nonetheless serious diseases impacting hundreds of thousands of Canadians. Many of those rare diseases are affecting the nervous system and are called neurodegenerative diseases. Ataxias are part of this group. Patients affected by ataxias mainly suffer of a lack of voluntary coordinate movements due to degeneration of part of the nervous system responsible for this coordination. Many patients are also presenting other neurological symptoms such as mental retardation, sensory impairment, etc. The diagnosis of this group of diseases is difficult due to an important variability in the symptoms even in patients from a same family. For many forms of ataxias, the genes responsible have not yet been identified. In the context of the Care for Rare (C4R) project, a pan-Canadian consortium configured to improve the diagnosis of rare diseases; we are aiming to study the genetic causes of ataxias. We will use new powerful DNA sequencing methods to perform a genetic mutational study of the entire coding exons (exomes) on selected patients. This will enable us to uncover novel causative genes and better describe the clinical variability in those disorders by identifying new mutations in known genes. This work will enhance the quality of genetic counseling for ataxia patients throughout Canada. It will also allow a better understanding of the molecular pathways involved in hereditary ataxias and may lead to novel treatments strategies.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tetreault, Martine
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~